Sign inGet started

GOLDBERG MICHAEL M

Insider CIK 905011 · ECTE Director · ALQA.OB Director · NAVB President & CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2017-05-162017-05-16106,021$0.46 $48.8K5,921,023SEC↗
ECTE Echo Therapeutics, Inc. A Award2017-03-212017-03-2325,000— $039,500SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS X Exercise deriv2017-01-172017-01-195,411,850— $00SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS X Exercise2017-01-172017-01-195,411,850$0.01 $54.1K5,815,002SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS J Other deriv2016-10-172016-10-195,411,850$2.07 $11.20M5,411,850SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2016-07-062016-07-0743,580$0.50 $21.8K403,152SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2016-04-202016-04-2928,000— $0359,572SEC↗
ECTE Echo Therapeutics, Inc. A Award deriv2016-03-212016-03-22150,000— $018,750SEC↗
ECTE Echo Therapeutics, Inc. A Award deriv2016-03-012016-03-03150,000— $037,500SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2015-10-082015-10-2013,247$2.26 $29.9K331,572SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2015-03-262015-03-3022,000— $0318,325SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2015-02-052015-02-096,614$1.89 $12.5K296,325SEC↗
ECTE Echo Therapeutics, Inc. A Award deriv2015-01-072015-01-12150,000$1.62 $243.0K150,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2014-11-142014-11-1728,359$1.12 $31.8K289,711SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2014-11-132014-11-1771,641$1.06 $75.9K261,352SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2014-11-102014-11-129,470$1.32 $12.5K189,711SEC↗
ECTE Echo Therapeutics, Inc. A Award deriv2014-02-282014-03-1756,000— $056,000SEC↗
ECTE Echo Therapeutics, Inc. A Award2014-02-282014-03-1714,500— $014,500SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2014-02-132014-02-1820,000— $0180,241SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2013-11-182013-11-2012,250— $0160,241SEC↗
ALQA.OB Alliqua, Inc. A Award deriv2012-05-142012-05-1675,000— $01,325,000SEC↗
ALQA.OB Alliqua, Inc. P Buy deriv2012-02-162012-02-211,000,000— $03,250,000SEC↗
ALQA.OB Alliqua, Inc. P Buy2012-02-162012-02-212,000,000— $02,250,000SEC↗